European Institute of Oncology: Prostatic Neoplasms trials

The registry lists 14 Prostatic Neoplasms studies with European Institute of Oncology as lead sponsor. 11 are open to participants now and 0 have results posted.

Phase 2 1No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• RE-irradiation for Isolated FOCal Recurrence of Prostate Cancer With Ultrahypofracted SBRTNot yet recruitingNCT07810660
• Minimal Residual Disease in Solid MalignanciesNot yet recruitingNCT07268469Not applicable
• Personalization of External Beam Radiation Therapy in Localised TumoursRecruitingNCT07047495
• Implementation of a New Algorithm for HRR Gene Mutation Testing in Patients With mPC Through Liquid Biopsy IntegrationRecruitingNCT06762379
• Role of Caregiver in the Clinical Pathway of Patients With Breast and Prostate CancerRecruitingNCT06468293Not applicable
• CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancErRecruitingNCT06331013Not applicable
• Response Evaluation of Cancer Therapeutics in Metastatic Castration-Resistant Prostate Cancer to the BoneRecruitingNCT06321679
• All-in-One Prostate Cancer Staging with MRIRecruitingNCT06071195
• Impact of Augmented Reality During Robot-assisted Radical ProstatectomyRecruitingNCT06059859Not applicable
• Radioablation With or Without Androgen DeprIvation Therapy in Metachronous Prostate Cancer OligometaStAsisRecruitingNCT03940235Phase 2
• Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate CancerRecruitingNCT02672449Not applicable
• Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy.Status unknownNCT05596851
• Intervention Study in Prostate Cancer Patients Undergoing RadiotherapyActive, not recruitingNCT05155618Not applicable
• Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant LesionActive, not recruitingNCT01913717Not applicable